A STUDY TO INVESTIGATE HOW EFFECTIVE AND SAFE SOLIFENACIN SUCCINATE SUSPENSION IS IN TREATING CHILDREN/ADOLESCENTS AGED 5 TO LESS THAN 18 YEARS WITH SYMPTOMS OF OVERACTIVE BLADDER (OAB) COMPARED TO A NON-ACTIVE DRUG: